Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 41 | 0 | 0 | 50 |
| Cost of Goods | N/A | 27 | N/A | N/A | N/A |
| Gross Profit | N/A | 13 | N/A | N/A | 50 |
| Operating Expenses | 2,202 | 971 | 594 | 491 | 444 |
| Operating Income | -2,202 | -930 | -594 | -491 | -394 |
| Interest Expense | 269 | 63 | 0 | 0 | 0 |
| Other Income | -195 | -20 | -375 | 847 | -719 |
| Pre-tax Income | -2,666 | -1,013 | -970 | 357 | -1,113 |
| Net Income Continuous | -2,666 | -1,013 | -970 | 357 | -1,113 |
| Net Income Discontinuous | -371 | N/A | N/A | N/A | N/A |
| Net Income | $-3,038 | $-1,013 | $-970 | $357 | $-1,113 |
| EPS Basic Total Ops | -0.06 | -0.04 | -0.02 | 0.01 | N/A |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.02 | 0.01 | N/A |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | -0.04 | -0.02 | 0.01 | N/A |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.02 | 0.01 | N/A |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,355 | $-869 | $-577 | $-491 | $-394 |